The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia A.

作者信息

Aronson D L

机构信息

George Washington University Medical Center, Washington, DC.

出版信息

Transfusion. 1990 Oct;30(8):748-58. doi: 10.1046/j.1537-2995.1990.30891020338.x.

DOI:10.1046/j.1537-2995.1990.30891020338.x

PMID:2120808

Abstract

摘要

相似文献

The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia A.

Transfusion. 1990 Oct;30(8):748-58. doi: 10.1046/j.1537-2995.1990.30891020338.x.

[Cryamine--a new factor VIII preparation].[克赖明——一种新型的凝血因子VIII制剂]

Gematol Transfuziol. 1989 Aug;34(8):53-6.

Transient inhibitor to monoclonal antibody-purified factor VIII concentrate.单克隆抗体纯化的凝血因子VIII浓缩物的瞬时抑制剂

Am J Hematol. 1992 Dec;41(4):297. doi: 10.1002/ajh.2830410417.

Preparation of and clinical experience with antihemophilic factor concentrates.抗血友病因子浓缩剂的制备及临床经验

Thromb Diath Haemorrh Suppl. 1968;35:49-59.

In vivo effectiveness of a high-yield factor VIII concentrate prepared in a blood bank.血库制备的高产量凝血因子VIII浓缩物的体内有效性。

N Engl J Med. 1984 Aug 2;311(5):310-3. doi: 10.1056/NEJM198408023110507.

Production of high-potency cryoprecipitate from exercised blood donors and the treatment of hemophilia A with this material.

Am J Clin Pathol. 1974 Oct;62(4):496-501. doi: 10.1093/ajcp/62.4.496.

[Cryoprecipitates rich in factor VIII. In vitro and in vivo studies].

Rev Fr Transfus. 1969 Dec;12(4):439-50. doi: 10.1016/s0035-2977(69)80110-0.

Cryoprecipitate therapy in haemophilia.

Scott Med J. 1969 Jan;14(1):1-9. doi: 10.1177/003693306901400101.

Acquired circulating anticoagulants in hemophilia A.

N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.

[Recombinant factor VIII].[重组凝血因子 VIII]

Sangre (Barc). 1993 Apr;38(2):139-42.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验